Drug Channels

JANUARY 28, 2022

It's a moderated discussion with payers on how the changing market might impact their management strategies in immunology. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Biosimilars 98

Biosimilars Marketing Drugs 98

Drug Channels

MAY 23, 2023

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 28, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights.

Marketing 98

Marketing Science Therapies Production 98

Drug Channels

MARCH 8, 2022

Next week, Drug Channels Institute will release our 2022 Economic Report on U.S. It’s the 13th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 9, 2024

Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription dispensing revenues reached $621 billion in 2023, driven by accelerating GLP-1 prescriptions and an expanding post-pandemic market. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Pharmacy 98

Pharmacy Marketing Hospitals Drugs 98

Drug Channels

JUNE 6, 2022

Time for an update to the Drug Channels Institute (DCI) annual analysis of pharmacist salaries and employment. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Expect further declines as the shakeout continues.

Pharmacy 98

Pharmacy Hospitals Marketing Drugs 98

Drug Channels

MAY 9, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. FYI, Managed Healthcare Executive (accurately) described my presentation as " mixing jokes with data and PowerPoint slides." Yes, that sounds about right.

Specialty Pharmacies 98

Specialty Pharmacies Marketing Pharmacy Drugs 98

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. How will GoodRx and Mark Cuban Cost Plus Drug Company affect the pharmacy industry? Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

APRIL 18, 2023

Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program. The IRA will alter many crucial aspects of the Medicare program and the overall drug channel. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

JANUARY 4, 2024

Paula and I have some exciting news to share with you: Drug Channels Institute is joining the HMP Global family! HMP is a leading omnichannel healthcare education, events, and market insights company. Please enjoy our special video message to the Drug Channels community: Click here if you can’t see the video.

Drugs 97

Drugs Marketing 97

Drug Channels

JUNE 20, 2023

Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program. The IRA will alter many crucial aspects of the Medicare program and the overall drug channel. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

DECEMBER 13, 2024

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. ET, you can attend the live event.)

Government 98

Government Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

JULY 5, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

MARCH 4, 2025

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. to 1:30 p.m. WHAT YOU WILL LEARN Join industry expert Adam J.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

OCTOBER 28, 2021

Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. To learn more about technology and access to specialty medications, read the CoverMyMeds Medication Access Report: Complex Care & Specialty Edition.

Marketing 75

Marketing Drugs 75

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

JANUARY 18, 2022

Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. Click here to order the Drug Channels 2022 Video Webinar Series. drug channel. drug channel.

Drugs 98

Drugs Marketing 98

Drug Channels

SEPTEMBER 24, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. That means it’s time to update Drug Channels Institute’s (DCI) annual analysis of pharmacist salaries and employment. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Hospitals 69

Hospitals Marketing Drugs Pharmacy 69

Drug Channels

APRIL 4, 2023

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

SEPTEMBER 14, 2022

These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. I’ll share DCI’s latest market data to help you stay on top of new developments. Click here to order the Drug Channels 2023 Video Webinar Series. d/b/a Drug Channels Institute.

Drugs 97

Drugs Marketing 97

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

MARCH 5, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Drug Channels

AUGUST 8, 2023

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. Click here to read the Drug Channels Institute letter to Senators Thune, Stabenow, Moore Capito, Baldwin, Moran, and Cardin. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. I shared my $0.02

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

JUNE 21, 2023

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

JULY 20, 2022

Join me next week for my new live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook , on July 29, 2022, from 12:00 p.m. I’ll cover market trends, payer strategies, channel developments, key trends that will help you plan for the future, and more. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Biosimilars 98

Biosimilars Pharmacy Drugs Marketing 98

Drug Channels

APRIL 26, 2022

In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day! d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Doctors Drugs 98

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

OCTOBER 6, 2020

The biosimilar market is finally beginning to fulfill its promise. The latest data show that provider-administered biosimilar drugs are successfully displacing their reference biological products. What’s more, manufacturers of reference products are cutting drug prices to defend their market shares.

Biosimilars 52

Biosimilars Marketing Regulations FDA 52

Drug Channels

JULY 25, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. The highly-consolidated PBM market notched another year of increased concentration. Significant business relationships among the largest companies continue to shift market share.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 5, 2022

The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. Significant business relationships among the largest companies continue to shift market share.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 7, 2023

Today’s guest post comes from Heather Roulston, Market Research Manager at MMIT. Using MMIT’s proprietary data, Heather demonstrates that contracting for medical benefit drugs is now common for many therapeutic areas. For additional market insights, click here to learn about MMIT’s Biologics & Injectables Index.

Marketing 98

Marketing Production Drugs Research 98

Drug Channels

MAY 9, 2024

To learn more about navigating the complexities of market access, contact MMIT and its sister company, The Dedham Group. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. They discuss five ways manufacturers can prevent these barriers from affecting patients. All rights reserved.

Therapies 98

Therapies Marketing Drugs 98

Drug Channels

NOVEMBER 14, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. This event is part of The Drug Channels 2023 Video Webinar Series. Dr. Adam J.

Pharmacy 98

Pharmacy Drugs Biosimilars Marketing 98

Drug Channels

APRIL 12, 2023

In Drug Channels Institute’s list of the top 15 pharmacies of 2022 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Independent Pharmacies Hospitals 98

Drug Channels

OCTOBER 14, 2022

Today’s guest post comes from Steve Callahan, Senior Manager of Market Research at MMIT. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Read on for Steve’s insights.

Biosimilars 98

Biosimilars Pharma Companies Marketing Research 98